Hutchinson-Gilford progeria syndrome: Cardiovascular manifestations and treatment

Mech Ageing Dev. 2023 Dec:216:111879. doi: 10.1016/j.mad.2023.111879. Epub 2023 Oct 11.

Abstract

Hutchinson-Gilford progeria syndrome (HGPS), also known as hereditary progeria syndrome, is caused by mutations in the LMNA gene and the expression of progerin, which causes accelerated aging and premature death, with most patients dying of heart failure or other cardiovascular complications in their teens. HGPS patients are able to exhibit cardiovascular phenotypes similar to physiological aging, such as extensive atherosclerosis, smooth muscle cell loss, vascular lesions, and electrical and functional abnormalities of the heart. It also excludes the traditional risk causative factors of cardiovascular disease, making HGPS a new model for studying aging-related cardiovascular disease. Here, we analyzed the pathogenesis and pathophysiological characteristics of HGPS and the relationship between HGPS and cardiovascular disease, provided insight into the molecular mechanisms of cardiovascular disease pathogenesis in HGPS patients and treatment strategies for this disease. Moreover, we summarize the disease models used in HGPS studies to improve our understanding of the pathological mechanisms of cardiovascular aging in HGPS patients.

Keywords: Aging; Cardiovascular disease; HGPS; Progerin.

MeSH terms

  • Adolescent
  • Aging / metabolism
  • Atherosclerosis* / pathology
  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / therapy
  • Cardiovascular System* / metabolism
  • Humans
  • Progeria* / genetics
  • Progeria* / metabolism
  • Progeria* / therapy